Kedrion Expands Ryplazim Distribution Network for PLGD-1 Patients
Published on Mon 24 Mar 2025 9:29:45 UTC
kedrion.us (PRNewsfoto/Kedrion Biopharma)
RYPLAZIM (plasminogen, human-tvmh) is plasma-derived human plasminogen indicated for the treatment of patients with plasminogen deficiency type 1 (PLGD-1) (PRNewsfoto/Kedrion Biopharma)
